| Dataset | DGIdb Drug Targets 2026 |
| Category | physical interactions |
| Type | drug |
| Description | An organic heterotricyclic compound that is [1,2,4]triazolo[3,4-f][1,6]naphthyridin-3(2H)-one substituted at positions 8 and 9 respectively by 4-(1-aminocyclobutyl)phenyl and phenyl groups. (Chemical Entities of Biological Interest Ontology, CHEBI_67271) |
| External Link | https://dgidb.org/results?searchType=drug&searchTerms=MK-2206 |
| Similar Terms | |
| Downloads & Tools |
6 interacting proteins for the MK-2206 drug from theDGIdb Drug Targets 2026 dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| UBE2T | ubiquitin-conjugating enzyme E2T | 13.233 |
| AKT3 | v-akt murine thymoma viral oncogene homolog 3 | 0.54135 |
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.504114 |
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.29048 |
| SMAD3 | SMAD family member 3 | 0.0450485 |
| AR | androgen receptor | 0.0119351 |